References
- Kano M , Ohno-ShosakuT, HashimotodaniYet al. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev.89, 309–380 (2009).
- Pertwee RG , HowlettAC, AboodMEet al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB and CB. Pharmacol. Rev.62, 588–631 (2010).
- Volkow ND , ComptonWM, WeissSR. Adverse health effects of marijuana use. N. Engl. J Med.371, 879 (2014).
- Calvigioni D , HurdYL, HarkanyTet al. Neuronal substrates and functional consequences of prenatal cannabis exposure. Eur. Child Adolesc. Psychiatry23, 931–941 (2014).
- Huizink AC , MulderEJ. Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci. Biobehav. Rev.30, 24–41 (2006).
- Rogeberg O . Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status. Proc. Natl. Acad. Sci. U. S. A.110, 4251–4254 (2013).
- Maccarrone M , GuzmanM, MackieKet al. Programming of neural cells by (endo) cannabinoids: from physiological rules to emerging therapies. Nat. Rev. Neurosci.15, 786–801 (2014).
- Gao Y , VasilyevDV, GoncalvesMBet al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J. Neurosci.30, 2017–2024 (2010).
- Aguado T , PalazuelosJ, MonoryKet al. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J. Neurosci.26, 1551–1561 (2006).
- Berghuis P , RajnicekAM, MorozovYMet al. Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science316, 1212–1216 (2007).
- Hurd YL , WangX, AndersonVet al. Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol. Teratol.27, 221–229 (2005).
- Mechoulam R , HanusLO, PertweeRet al. Early phytocannabinoid chemistry to endocannabinoids and beyond. Nat. Rev. Neurosci.15, 757–764 (2014).
- Blankman JL , SimonGM, CravattBF. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol.14, 1347–1356 (2007).
- Herkenham M , LynnAB, LittleMDet al. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA87, 1932–1936 (1990).
- Berrendero F , SepeN, RamosJAet al. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse33, 181–191 (1999).
- Tortoriello G , MorrisCV, AlparAet al. Miswiring the brain: delta9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway. EMBO J.33, 668–685 (2014).
- Fonseca BM , Correia-da-SilvaG, TaylorAHet al. The endocannabinoid 2-arachidonoylglycerol (2-AG) and metabolizing enzymes during rat fetoplacental development: a role in uterine remodelling. Int. J. Biochem. Cell Biol.42, 1884–1892 (2010).
- Iannotti FA , SilvestriC, MazzarellaEet al. The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels. Proc. Natl. Acad. Sci. USA111, E2472–E2481 (2014).